NCT06666998View on ClinicalTrials.gov

Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
EravacyclinePharmacokineticsBacteria InfectionBacterial Resistance to AntimicrobialEmpirical Antimicrobial Therapy
All Listed Sponsors
lead

Sichuan Provincial People's Hospital

OTHER

NCT06666998 - Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients | Biotech Hunter | Biotech Hunter